Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases
Takeshi Aiba,
Kengo Kusano,
Michikazu Nakai,
Kohei Ishibashi,
Tsukasa Kamakura,
Mitsuru Wada,
Koji Miyamoto,
Satoshi Nagase,
Koshiro Kanaoka,
Yoshihiro Miyamoto,
Keiko Shimamoto,
Kenichiro Yamagata,
Yoshitaka Iwanaga,
Reina Tonegawa-Kuji,
Yoko Sumita,
Yuko Y Inoue,
Yuichiro Miyazaki,
Akinori Wakamiya,
Nobuhiko Ueda,
Kenzaburo Nakajima
Affiliations
Takeshi Aiba
Department of Clinical Laboratory and Genetics, National Cerebral and Cardiovascular Center, Suita, Japan
Kengo Kusano
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Michikazu Nakai
2 Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Kohei Ishibashi
1 Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Tsukasa Kamakura
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Mitsuru Wada
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Koji Miyamoto
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Satoshi Nagase
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Koshiro Kanaoka
2 Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Yoshihiro Miyamoto
3 Open Innovation Center, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Keiko Shimamoto
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Kenichiro Yamagata
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Yoshitaka Iwanaga
Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Reina Tonegawa-Kuji
Departmenf of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
Yoko Sumita
2 Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Yuko Y Inoue
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Yuichiro Miyazaki
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Akinori Wakamiya
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Nobuhiko Ueda
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Kenzaburo Nakajima
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Objectives To identify differences in patient characteristics, clinical practice and outcomes of cardiac implantable electronic device (CIED) therapy between Japan and the USA.Design A cross-sectional study.Setting Nationally representative administrative databases from Japan and the USA containing hospitalisations with first-time implantations of pacemakers, implantable cardioverter-defibrillators (ICD) and cardiac-resynchronisation therapy with or without defibrillators (CRTP/CRTD).Participants Patients hospitalised with first-time implantations of CIEDs.Outcome measures In-hospital mortality, in-hospital complication and 30-day readmission rates.Results Overall, 107 339 (median age 78 (71–84), 48 415 women) and 295 584 (age 76 (67–83), 127 349 women) records with CIED implantations were included from Japan and the USA, respectively. Proportion of women in defibrillator recipients was lower in Japan than in the USA (ICD, 21% vs 28%, p<0.001; CRTD, 24% vs 29%, p<0.001). Length of stay after CIED implantation was longer in Japan than in the USA for all device types (conventional pacemaker, 8(7–11) vs 1 (1–3) days, p<0.001; leadless pacemaker, 5 (3–9) vs 2 (1–5) days, p<0.001; ICD, 8 (7–11) vs 1 (1–3) days, p<0.001, CRTP, 9 (7–13) vs 2 (1–4) days, p<0.001; CRTD, 9 (8–14) vs 2 (1–4) days, p<0.001). In-hospital mortality after CIED implantation was similar between Japan and the USA ((OR) (95% CI), conventional pacemaker 0.58 (0.83 to 1.004); ICD 0.77 (0.57 to 1.03); CRTP 0.85 (0.51 to 1.44); CRTD 1.11 (0.81 to 1.51)), except that after leadless pacemaker implantation in Japan was lower than that in the USA (0.32 (0.23 to 0.43)). 30-day readmission rates were lower in Japan than in the USA for all device types (conventional pacemaker 0.55 (0.53 to 0.57); leadless pacemaker 0.50 (0.43 to 0.58); ICD 0.54 (0.49 to 0.58); CRTP 0.51 (0.42 to 0.62); CRTD 0.57 (0.51 to 0.64)).Conclusions International variations in patient characteristics, practice and outcomes were observed. In-hospital mortality after CIED implantation was similar between Japan and the USA, except in cases of leadless pacemaker recipients.